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We evaluated the efficacy of the Minimally Invasive Limited
Ligation Endoluminal-Assisted Revision (MILLER) banding
procedure in treating dialysis-associated steal syndrome or
high-flow access problems. A retrospective analysis was
conducted, evaluating banding of 183 patients of which 114
presented with hand ischemia (Steal) and 69 with clinical
manifestations of pathologic high access flow such as
congestive heart failure. Patients were assessed for technical
success and symptomatic improvement, primary and
secondary access patency, and primary band patency.
Overall, 183 patients underwent a combined 229 bandings
with technical success achieved in 225. Complete
symptomatic relief (clinical success) was attained in 109
Steal patients and in all high-flow patients. The average
follow-up time was 11 months with a 6-month primary band
patency of 75 and 85% for Steal and high-flow patients,
respectively. At 24 months the secondary access patency was
90% and the thrombotic event rates for upper-arm fistulas,
forearm fistulas, and grafts were 0.21, 0.10, and 0.92 per
access-year, respectively. Hence, the minimally invasive
MILLER procedure appears to be an effective and durable
option for treating dialysis access-related steal syndrome and
high-flow-associated symptoms.
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On the creation of a hemodialysis access, a low-resistance
venous pathway is connected to the arterial circuit. This
creates the potential for several problems, which cover a
spectrum of disease from dialysis-associated steal syndrome
(Steal) to high-output cardiac overload. The ideal access
functions with just enough pressure and flow to prevent
thrombosis while maximizing hemodialysis efficiency. The
range of blood flow within a typical dialysis access can be
divided into low (o600ml/min), normal (600–1500ml/min),
and high (1500–4000ml/min) categories.1 However, the range
of flow in the access has very little correlation with patient
symptoms. A low-flow access (o600ml/min) can cause both
Steal and cardiac overload, depending on the degree of pre-
existing systemic vascular disease and cardiac dysfunction.
Conversely, a high-flow access (1500–4000ml/min) may cause
neither Steal nor cardiac overload symptoms.2 Proposed treat-
ments are entirely based on clinical symptoms rather than
attempts to normalize access flow.
Steal syndrome develops in 2.7–4.3% of arteriovenous
grafts (AVGs) and 1% of arteriovenous fistulas (AVFs).3,4 It is
clinically defined as hypoperfusion distal (more peripheral)
to the hemodialysis access due to the access diverting an
excessive amount of blood away from the distal artery
(Figure 1). Increased resistance in the distal arteries
(microvascular and macrovascular disease) contributes to
the diversion of blood into the AV access, exacerbating distal
hypoperfusion and frequently resulting in ischemic symp-
toms.5 If untreated, Steal can lead to debilitating neuropathy
and tissue loss.
High flow within an AV access develops over time. As the
AV access ages, increased flow within the artery and vein
induces dilatation, resulting in a gradual reduction in
resistance.6 The resultant high-flow circuit potentially leads
to prolonged post-dialysis bleeding, problematic elevation of
venous pressures, pathologically accelerated access growth,
and cardiac overload.2,7
Banding is a technique that has commonly been used to
correct these access dysfunctions by reducing access flow.
The introduction of a high-resistance band is a reasonable
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treatment for a low-resistance venous pathway, which has
transformed a functional access into a pathologic shunt.
Banding of these accesses was first described8 shortly after the
introduction of AV shunts for hemodialysis.9 Various
banding techniques have been described in published
studies,10–13 but complexities in sizing the band14,15 and the
resultant poor long-term outcomes have led to near
abandonment of banding16 and the development of alter-
native treatments such as distal revascularization with
interval ligation (DRIL)17 and proximalization of the arterial
inflow (PAI).18
We are presenting the development of a precision
modification to traditional banding procedures. The original
Minimally Invasive Limited Ligation Endoluminal-Assisted
Revision (MILLER) study included a cohort of 16 patients
and treatment was confined to patients showing Steal
symptoms.19 Since its introduction, we have extended the
use of the MILLER procedure to treat the full spectrum of
low-resistance pathologic flow from Steal to High Flow
within the access.
RESULTS
Outcomes
The incidence of Steal and High Flow requiring treatment in
our practice wasB6%. The 183 patient cohort contained 156
upper-arm accesses (78 brachiocephalic AVFs, 58 transposed
brachiobasilic AVFs, and 20 AVGs) and 27 forearm accesses.
A total of 114 patients were classified as Steal and 69 patients
were classified as High Flow.
An access band was created (technical success) in 225 of
229 (98%) of banding attempts. Overall, 89% of Steal and
94% of High Flow patients achieved clinical success
(complete symptomatic relief) with the initial banding, and
96% of Steal and 100% of High Flow patients ultimately
attained clinical success with one or more bandings. The
most common first band size was 4mm (57%) diameter
(range, 2.5–6mm) for fistulas and 3mm (52%) for grafts
(range, 3–4mm). The total procedure time from initial access
cannulation to closure of the skin ranged from 30 to 90min.
Of four technical failures, three were due to instances of
access bleeding, which led to abandonment of the procedure,
and rebandings were successfully performed B3 weeks later.
In the fourth patient, the arterial anastomosis was located
under the usable portion of the fistula body; this access was
subsequently banded by the MILLER sizing technique during
an open surgical procedure.
Clinical success was not achieved in 17 (9%) of our initial
bandings, with patients experiencing only partial improve-
ment. Of the 183 (7%) patients, 12 achieved clinical success
with two or three banding attempts. Of the remaining five
patients, three continued to use their access with partial (but
tolerable) symptomatic relief and two required access ligation
owing to persistent steal and resultant tissue loss (Tables 1
and 2).
Steal patients requiring multiple bandings had a signifi-
cantly lower prevalence of hypertension (P¼ 0.003). The
most common angiographic findings were complete occlu-
sion of at least one forearm artery and an incomplete palmar
arch, with a frequency of 67% (versus 9% in the total Steal
cohort). Distal occlusion of both the ulnar and radial arteries
was present in the two patients who underwent access
ligation owing to persistent steal.
High Flow patients were significantly younger (t¼ 3.1,
P¼ 0.002) and had a decreased prevalence of diabetes
(t¼ 4.87, P¼ 0.001) compared with the Steal cohort (Tables
1 and 2). Overall, 100% of High Flow patients requiring
multiple bandings had angiographically shown proximal
brachial artery hypertrophy beyond 9mm diameter (versus
29% in the total High Flow cohort and 0% in the Steal
cohort).
The mean follow-up time was 11 months (range, 0.25–37).
Steal and High Flow patients received percutaneous
interventions at a rate of 2.96 and 3.53 per access-year,
respectively. The most common post-banding intervention
was angioplasty of venous outflow stenoses, accounting for
85% of interventions. Stretching of the band was performed
at a rate of 0.10 and 0.34 per access-year in fistulas and grafts,
respectively. In two patients with fistulas the banding site was
problematic, requiring repeat angioplasty treatments (every
2–3 months). Banding-related thrombectomies (thrombosis
within 30 days) were performed on 5 of 114 Steal and 1 of 69
of High Flow patients. All six patients had successful
percutaneous thrombectomies. The thrombotic event rate
for upper-arm fistulas, forearm fistulas, and grafts was 0.21,
0.10 and 0.92 per access-year, respectively. No aneurysms
developed distal to the banding site.
The primary band patency for Steal and High Flow
patients was 75 and 85% at 6 months, respectively (Figure 2).
The primary access patency for Steal and High Flow patients
was 52 and 63% at 3 months, with a secondary access
Brachial artery
100% flow
25% flow
(from brachial artery)
75% flow
(into fistula body)
Fistula body
Cephalic vein
Figure 1 | Steal syndrome in a brachiocephalic fistula with
distal hypoperfusion.
360 Kidney International (2010) 77, 359–366
or ig ina l a r t i c l e GA Miller et al.: The MILLER banding procedure
patency of 90 and 89% at 24 months, respectively (Figure 3).
The secondary access patencies of elderly (465 years) and
diabetics were not significantly different from the total cohort
(w2¼ 2.5, P¼ 0.11 and w2¼ 0.19, P¼ 0.66, respectively). The
secondary access patency of the 16 patients from the initial
MILLER banding reports19 was 77% at 36 months.
Three of our graft banding patients had previously
undergone DRIL procedures and received 3mm diameter
bandings to augment effectiveness of the bypass. Five of our
fistula banding patients had previously undergone traditional
open surgical banding procedures and were rebanded using
the MILLER technique.
Measurements
In a subset of patients, flow and pressure measurements were
obtained. The average initial flow in Steal (n¼ 8) and High
Flow (n¼ 12) patients was 2034 and 2629ml/min, and the
average flow reduction was 1046 (50%) and 1354ml/min
(52%), respectively. In Steal and High Flow patients (n¼ 4),
the average initial intra-access pressure was 45mmHg and the
average pressure reduction was 23.5mmHg (51.4%).
Follow-up
A total of eight Steal patients and two High Flow patients
died during the follow-up period; however, their deaths were
unrelated to the procedure and their accesses were patent at
the time of death. Six patients had kidney transplants during
follow-up.
Complications
Major complications occurred in two patients with AVGs and
one patient with an AVF. These patients developed cellulitis,
which spread from our transverse incision to the AV access,
resulting in access ligation and graft removal within 14 days.
The protocol was then modified to include antibiotic
prophylaxis. In addition, the dissection technique was
Table 1 | Patient demographics of the steal cohorta
Complete improvement
after 1 banding
Complete improvement
after 2–3 bandings
Partial improvement
after 2–3 bandings
Failure (access ligation
owing to persistent steal)
101 (89) 8 (7) 3 (3) 2 (2)
Upper-arm fistulas 70 (61) 5 (4) 2 (2) 0 (0)
Forearm fistulas 12 (11) 0 (0) 0 (0) 2 (2)
Upper-arm grafts 19 (17) 3 (3) 1 (1) 0 (0)
Sex (M/F) 52/49 2/6 2/1 1/1
Hypertension 72 (73) 2 (25) 2 (67) 1 (50)
Diabetes mellitus 75 (76) 4 (50) 3 (100) 2 (100)
Average age (years) 62 65 66 65.5
Abbreviations: F, female; M, male.
aThe numbers in parentheses are percentages; the values were rounded off and hence do not add up to 100%.
Table 2 | Patient demographics of the High Flow cohorta
Complete improvement after
1 banding
Complete improvement
after 2–3 bandings
65 (94) 4 (6)
Upper-arm
fistulas
57 (83) 2 (3)
Forearm
fistulas
4 (6) 2 (3)
Upper-arm
grafts
4 (6) 0 (0)
Sex (M/F) 40/25 3/1
Hypertension 51 (78) 3 (75)
Diabetes
mellitus
23 (35) 0 (0)
Average age
(years)
56 53
Abbreviations: F, female; M, male.
aThe numbers in parentheses are percentages; the values were rounded off and
hence do not add up to 100%.
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Figure 2 |Primary band patency for dialysis-associated steal
syndrome (Steal) and High Flow patients (24 months).
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Figure 3 | Secondary access patency for dialysis-associated
steal syndrome (Steal) and High Flow patients (24 months).
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modified to consist of two lateral incisions instead of one
transverse incision (with full exposure of the access).19 No
infections occurred in the 179 subsequent procedures.
Minor complications included three cases of access (two
AVFs and one AVG) bleeding during the procedure. These
were treated with manual compression of the injured area
until bleeding subsided, and did not result in delayed
hemodialysis treatments. No patients required hospitalization
or open surgical repair to control bleeding.
DISCUSSION
The introduction of a high-resistance band should correct
steal and high flow in vascular accesses by diminishing access
flow, and restoring sufficient distal arterial flow and
perfusion. In accesses with normal to high flow, banding is
appropriate but requires the operator to precisely control the
diameter of the band.14,15,20 Thermodilution-based flow
measures are inaccurate when access flow reduction is used
as a surrogate for distal arterial flow enhancement.
Techniques such as finger plethysmography and the digital-
brachial index21,22 are measures of distal perfusion, but their
utility is severely limited intra-operatively by changes in
blood pressure, heart rate, and cardiac output experienced
during administration of general anesthesia. When used as
independent measures to adjust band size, they have
suboptimal outcomes.21 Combined, these techniques have
yielded acceptable outcomes;20,23 however, they cannot be
standardized because of the influence of innumerable
confounding variables and such results may not be easily
reproducible by less experienced operators, using the same
parameters.
The use of an intraluminal balloon as a sizing dowel is
likely to prove useful not only for the minimally invasive
MILLER procedure but also during open surgical banding
procedures. The MILLER banding technique modulates band
size with great precision, eliminating the need for complex
flow and perfusion measurements. No expensive equipment
or advanced measurement devices were needed for any
patients. Using the sizing nomogram (Figure 4, Murray
et al.24), the decision-making process is simplified to the
creation of a band that results in a 60–80% reduction in
lumen diameter. Therefore, 7-mm-diameter grafts were
banded to 3mm, and 20-mm-diameter upper-arm fistulas
were banded to 5mm. To overcome high distal arterial
resistances, some forearm fistulas were banded to as little as
2.5mm. In cases where the ligature size was inadequate, it
was adjusted incrementally, as accesses were rebanded to a
smaller size. In cases of access thrombosis, the bands were
stretched, or even broken with a larger diameter angioplasty
balloon. No significant vessel wall injury occurred after band
breaking, as verified by follow-up angiograms.
Banding physiology is best explained by Poiseuille’s Law,
which states that fluid flow (Q) is proportional to radius (r),
pressure across a gradient (DP, for example, arterial
pressurecentral venous pressure) and inversely proportional
to resistances, length (L), and viscosity (Z): Q¼ (DPpr4)/
(8ZL). The MILLER banding technique decreases flow by
decreasing the radius at a specific point and, as a result, access
flow (Qaccess) and pressure is directly sacrificed to increase
distal arterial flow (Qdistal) and pressure. Therefore, in
accesses with low-flow (low Qaccess) steal, further flow
reduction could lead to access thrombosis. These patients
may benefit most from revasculatization procedures such as
DRIL17 and PAI,18 which enhance total extremity flow and
therefore enhance both Qdistal and Qaccess.
In the first patients we treated, complete symptomatic
relief was less important than avoidance of thrombotic
events; therefore, we conservatively used larger intraluminal
balloons (with a target of 60% lumen reduction) and then
repeated the procedure in 4 weeks if residual symptoms
persisted. With experience, estimation of initial band size
improved, as we came to understand that clinical success
could be more readily achieved (without inducing thrombo-
sis) with a lumen reduction of B75%. Flow measurements
during the procedure have further improved the accuracy of
our selection of initial band size.
In 9% of patients, rebandings were performed to enhance
clinical efficacy. The majority of patients who required
multiple bandings were Steal patients with low-normal blood
pressure and High Flow patients with severe hypertension, as
extremes of blood pressure made predicting the appropriate
band size more difficult. During a rebanding, the resistance of
a single band was augmented by placement of additional
bands to create a segment of resistance rather than a focus of
resistance. Such an increase in access resistance was necessary
to overcome the high flow of a hypertrophic proximal artery
in High Flow patients. Steal patients who required additional
bandings ultimately achieved clinical success as resistance in
the access increased beyond the peripheral resistance
associated with arterial occlusions. When these arteries are
occluded, the maximum Qdistal is decreased, and access flow
must be reduced to a much greater extent in order to
generate the flow and pressure necessary to divert a sufficient
amount of blood to collateral arteries. In two Steal patients
who required access ligation, the occlusion of both forearm
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Figure 4 |Band sizing nomogram. Reprinted with permission
from Murray et al.24 The sigmoidal function lines represent
arteriovenous fistulas of varying diameter (0.5–4 cm) and the
percentage of lumen reduction necessary to significantly reduce
total access flow.
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arteries made adequate Qdistal impossible to achieve without a
reduction of Qaccess that would make the access unusable.
Access interventions have historically been performed at
rates as high as 5.3 per access-year for fistulas and 3.7 per
access-year for grafts to decrease thrombotic events.25 In our
study, procedures were performed at a rate of 2.9 and
3.5 interventions per access-year in Steal and High Flow
accesses, respectively. The primary access patency was 56%
at 3 months, primarily due to the angioplasty of venous
outflow stenoses.
Previous studies have obtained thrombosis rates of 1.1 per
access-year in grafts25 and 0.13–0.57 per access-year in
fistulas.25–27 Given these results, our thrombosis rates of
0.20 per access-year in fistulas and 0.92 per access-year in
grafts are comparable with non-banding studies, suggesting
that the MILLER method of banding does not compromise
access durability in order to achieve the necessary flow
reduction.
In our study, secondary access patency remained high after
24 months (90%). By comparison, the largest DRIL study to
date (with grafts comprising 60% of accesses) obtained a 90%
rate of clinical success (Table 3), with a 6% rate of thrombosis
at an average follow-up of 7.4 months.28 In that study, as well
as others,29 accesses with persistent Steal were ligated. We
propose that the rate of DRIL clinical success can be further
augmented through the application of the MILLER banding
technique on such clinical failures, as three of our successfully
treated banding patients had previously undergone DRIL
procedures without complete symptomatic relief.
When approaching the banding procedure, the operator’s
initial concern is preventing and controlling access bleeding.
The three instances of access bleeding we encountered were
easily treated using focal pressure. In the event of bleeding,
once hemostasis was achieved, a new dissection was generally
started distal to the original site. A more distal dissection
location was chosen to avoid exposing the injured area to the
pressure gradient caused by the band. Using the same logic as
applied to the access as a whole, aggressive treatment of
venous outflow stenoses diminished intra-access pressure,
which we believe minimized the potential for bleeding
complications caused by a dissection injury.
Long-term potential complications include the develop-
ment of intimal hyperplasia narrowing the banding lumen
and aneurysms distal to the banding site. Aggressive intimal
hyperplasia of the fistula lumen occurred in two patients and
was treated with repeated balloon angioplasty across the
region of the band. Despite a palpable pressure gradient distal
to the band, no aneurysms developed. As all banding sites
were confined to the distal access, no needle cannulations
occurred in these areas. In addition, reduced intra-access
pressure (mean reduction of 51.4%) proximal to the banding
site appeared to attenuate further growth of mid-access
cannulation-related aneurysms.30
The MILLER procedure is useful for all accesses exhibiting
high flow and most accesses exhibiting steal syndrome. When
selecting the optimal treatment for such access dysfunctions,
the primary concerns are efficacy and invasiveness. The
MILLER banding procedure is the least invasive of all current
Table 3 | Review of the literature
Study Procedure Indication Access type
Patients
(n)
Symptom
resolution (%)
Secondary patency
at 12 months (%)
Flow reduction
(%)
Aschwanden et al.35 Banding Steal Fistula 3 100 100 68
DeCaprio et al.36 Banding Steal Graft 11 91 10 ND
Meyer et al.37 Banding Steal Fistula 7 100 ND ND
Morsy et al.3 Banding Steal Fistula and graft 6 67 33 ND
Odland et al.21 Banding Steal Fistula and graft 16 100 39 ND
Schneider et al.38 T-banding Steal Fistula and graft 6 83 100a 45
HF Fistula and graft 20 95 49
Thermann et al.39 Banding Steal Fistula 25 68 65b ND
Zanow et al.20 Banding Steal and CF Fistula 7 86 85 ND
Berman et al.40 DRIL Steal Fistula 21 100 94b ND
Haimov et al.41 DRIL Steal Fistula 23 96 73 ND
Katz et al.42 DRIL Steal Fistula and graft 12 100 ND ND
Knox et al.28 DRIL Steal Graft 52 90 83 ND
Korzets et al.43 DRIL Steal Fistula 9 100 ND ND
Lazarides et al.15 DRIL Steal Fistula 7 94 ND ND
Mwipatayi et al.29 DRIL Steal Fistula 12 92 100 ND
Schanzer et al.44 DRIL Steal Fistula and graft 14 83 100 ND
Sessa et al.45 DRIL Steal Fistula and graft 18 100 94 ND
Stierli et al.46 DRIL Steal Fistula 6 100 ND ND
Zanow et al.18 PAI Steal Fistula and graft 30 84 90 ND
Presented data MILLER banding Steal Fistula and graft 114 87 90 50
HF Fistula and graft 69 94 97 52
Abbreviations: CF, cardiac failure; DRIL, distal revascularization and interval ligation; HF, High Flow; MILLER, minimally invasive limited ligation endoluminal-assisted revision;
ND, no data; PAI, proximalization of the arterial inflow; RUDI, revision using distal inflow.
aAt 3 months.
bAt 18 months.
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treatments and its efficacy is now well established. As most
accesses exhibiting steal symptoms will likely have sufficient
proximal arterial flow, we believe the MILLER procedure
ought to be the initial treatment for Steal. However, in cases
of low-flow steal, DRIL or PAI may still be the optimal
treatments. The precise sizing of MILLER banding provides a
rapid way of achieving adequate balance between Qaccess
and Qdistal without diminishing access longevity over the
11-month average follow-up time of the study.
MATERIALS AND METHODS
Patient population
The patients were referred to 10 outpatient clinics in New York and
New Jersey by over 40 surrounding dialysis centers with an
estimated 10,000 dialysis lives. A total of 183 consecutive patients
(100 male and 83 female) who adhered to the inclusion/exclusion
criteria were treated with the MILLER banding procedure towing to
steal syndrome and high-flow fistulas between February 2005 and
April 2009. The banding procedures included in this study were
performed by 10 interventionalists, with experience levels ranging
from 1 year (for interventional nephrologists) to 30 years (for
interventional radiologists).
All patients provided written informed consent for the banding
procedure. No institutional review board existed at the author’s
institution at the time the study was initiated; therefore, the
principles of the Declaration of Helsinki were followed. A
retrospective analysis of patient records, digital images, and reports
was conducted. All relevant patient data (including demographics,
access type, symptoms, procedural complications, and access use at
dialysis) were recorded for each patient.
Inclusion/exclusion criteria
Patients were evaluated and categorized as ‘Steal’ or ‘High Flow’
according to their symptoms and physical examination.
Steal. A diagnosis of steal was established on clinical grounds.
Accesses were banded if they exhibited classic steal symptoms such
as numbness and coldness of the hand, which were exacerbated at
dialysis and alleviated by temporary shunt occlusion. The hand and
fingers were generally most symptomatic, but cramping and pain of
the muscles of the forearm and upper arm were also encountered.
Signs of steal ranged from pallor to tissue necrosis of the hand and
fingers. Angiography was then performed to confirm the diagnosis.
High flow. Diagnosis of a high-flow access was established on
clinical grounds. High-flow accesses were banded if the patients
developed decompensated congestive heart failure directly attribu-
table to AV access placement, visibly notable aneurysm growth, or
problematic elevation of venous pressures at dialysis.6,31 Patients
with simultaneous symptoms of both steal syndrome and high-
access flow were categorized as High Flow.
All patients who underwent banding after classification into the
Steal and High-Flow groups were included in the study. Patients
with limb ischemia related to proximal arterial stenoses, or arterial
stenoses amenable to angioplasty were excluded from the study.
Outcome definitions
Technical success was achieved when a band was created and the
patient underwent at least one successful hemodialysis treatment.
Any patient who achieved complete symptomatic improvement was
considered to have clinical success. Patients who experienced partial
(but adequate) symptomatic improvement were classified as having
partial improvement. A thrombectomy procedure performed within
30 days of the initial banding was considered to be banding-related.
Complications
Major complications were defined as any adverse sequelae that
resulted in fistula ligation, graft excision, open surgical repair of
bleeding, or hospitalization. Minor complications were defined as
those that did not interfere with hemodialysis treatments.
Primary and secondary patency statistical analysis
The Society of Interventional Radiology (SIR) reporting standards
for primary access patency and secondary patency were used.
Primary access patency is defined as the time between the initial
access intervention and any following repeat interventions. Primary
patency of the MILLER band ended with balloon dilation of existing
bands, rebanding, or access thrombosis. Secondary patency is
defined as the time of patency from the initial intervention until the
access was surgically revised, abandoned, or until transplantation,
death, and loss to follow-up.32 A Kaplan–Meier analysis was carried
out to construct a life-table estimate of fistula patency and band
patency. w2-Tests were used to test for the association between
secondary access patency and demographic characteristics of the
patients. Unpaired t-tests were performed to assess the relationship
between demographics and cohort classification.
Procedure
Angiography/pre-banding interventions. Access was gained
into the AVF/AVG toward the arterial inflow using a 21-g
microaccess needle and catheter (Cook, Bloomington, IN, USA).
Imaging (GE OEC 9800 Plus, GE Healthcare, Salt Lake City, Utah,
USA) using intravenous contrast (Ioxilan 62%, 300mg/ml; Guerbet
LLC) of the venous outflow was first performed to identify outflow
obstruction. A 5F vascular sheath (Pinnacle, Terumo Medical,
Elkton, MD, USA), 0.035-inch guidewire (Merit Medical Systems,
South Jordan, UT, USA), and a Bern catheter (Boston Scientific,
Natick, MA, USA) were used to gain access into the inflow artery
and perform arterial imaging. With the catheter in the proximal
feeding artery, extremity angiography was performed. If no contrast
flow was visualized distal to the access anastomosis, contrast
imaging of the distal arteries was performed with access compres-
sion to enhance contrast filling of these arteries. All Steal patients
underwent an upper extremity arteriogram and any diagnosed flow-
limiting axillary or brachial proximal arterial lesions were treated
with angioplasty (Ultra-thin Diamond Balloon, Boston Scientific/
Meditech, Watertown, MA, USA) and stent (Prote´ge´ EverFlex, ev3,
Plymouth, MN, USA) placement, as needed. Diffuse distal disease of
the ulnar and radial arteries was not treated.
Selection of the banding site. Palpation was used to find a site
adjacent to the arterial anastomosis where the access body was
mobile beneath the skin, indicating that the vein was free of
adherent scar tissue. Ultrasound (Terason, Burlington, MA, USA)
was used to determine access depth and the presence of adjacent
vascular structures. Angiography confirmed the location of the
arterial anastomosis and the size of the inflow artery, downstream
arteries, and diameter of the banding site. The goal was to find a
location in which the banding site would be as close to the
anastomosis as possible, yet superficial enough to facilitate an easy
dissection. In most cases, banding was performed within 1–3 cm of
the arterial anastomosis (Figure 5).
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Dissection. The procedure was performed using local anesthesia
(1% xylocaine) and intravenous conscious sedation with Fentanyl
(fentanyl citrate 50mg/ml; Hospira, Lake Forest, IL, USA) and Versed
(Midazolam HCl 2mg/2ml; Hospira). Intraprocedural monitoring
of blood pressure, electrocardiogram, and pulse oximetry was per-
formed (Datascope Passport 2, Datascope, Paramus, NJ, USA).
The original technique involved a transverse skin incision with
full exposure of the access. The current minimally invasive technique
involves two parallel, lateral 0.5 cm incisions, with a peri-access
tunnel dissected subcutaneously using Kelly clamp blunt dissection
(Figure 6). If incisional bleeding from the surrounding tissue was
encountered, hemostasis was achieved using 2–3min of focal
pressure. When more severe bleeding resulted from perforation
into the access, prolonged (5–20min) focal pressure was necessary.
Dissection was first performed under the access. A subcutaneous
2-0 monofilament ligature of Prolene (Ethicon, Somerville, NJ,
USA) was then pulled under the access (Figure 6). The second part
of the dissection was then under the skin, but over the access. The
suture was then looped around the access (Figure 6). An angioplasty
balloon was then inflated to 18 atmospheres of pressure in the area
encircled by the loop of suture. The ligature was tightened around
the balloon until there was no flow in the access (Figure 7). Six knots
were tied to minimize slippage of the Prolene suture. Once the
ligature was secured, the balloon was deflated and flow was restored.
Next, the access was palpated to ensure that access flow was
adequate.33,34 During the most recent 20 procedures, pre- and post-
procedure flow measurements (Flow Transonic, Transonic Systems,
Ithaca, NY, USA) and pressure measurements (TruWave Disposable
Pressure Transducer, Edwards Lifesciences, Irvine, CA, USA) were
obtained to help guide the interventionalist.
Angiography confirmed the procedure was complete when an
injection of contrast into the proximal artery showed enhanced
contrast run-off into the distal arteries while maintaining flow into
the dialysis access (Figure 8). Once complete, the incisions were
closed with Dermabond (Ethicon, Somerville, NJ, USA) adhesive
solution or 4.0 Vicryl (Ethicon) subcuticular sutures.
Balloon sizing. Balloon sizing was critical to the procedure.
Two factors were instrumental in helping to size the band. In Steal
patients, the band was equal to or smaller than the size of the
downstream artery, to ensure that resistance of the access was
significantly increased with respect to the resistance of the down-
stream artery. In High-Flow patients, the above rule applies, but a
nomogram illustrating the relationship between access diameter to
flow volume (Figure 4, Murray et al.24) was helpful. According to
the nomogram, lumen diameter needs to be reduced by 60–80% in
order to significantly affect the flow. Therefore, a visual estimation
of the banding site (before the banding) helped determine the final
lumen size needed to significantly reduce flow.
Banding modifications. Immediately after a band was created,
the balloon was deflated and removed. Following band placement,
palpation of access flow was the only tool used in the majority of
cases. If the flow was too slow, then a balloon with a diameter that
was 1mm larger was used to stretch the band (the knots in the
Prolene suture stretch to a small degree). If the patient reported
no symptomatic improvement and angiographic evidence of steal
Guide wire
Angioplasty balloon Incisions
Figure 5 |An inflated angioplasty balloon is used as a sizing
dowel inside the access. Two parallel, lateral 0.5 cm incisions are
made approximately 1–3 cm from the arteriovenous anastomosis.
Suture
Kelly clamp
(under skin, under vein)
Figure 6 |A peri-access tunnel is dissected subcutaneously
using Kelly clamp blunt dissection, and a 2-0 monofilament
ligature of Prolene is pulled under the access.
Suture
Kelly clamp
(under skin, over vein)
Figure 7 | The suture is looped over the access (under the skin)
using a Kelly clamp.
Brachial artery
100% flow
Cephalic vein
Closed suture50% flow
(from brachial artery)
50% flow
(into fistula body)
Figure 8 | Following the Minimally Invasive Limited Ligation
Endoluminal-Assisted Revision (MILLER) banding procedure,
the resistance band redirects flow, improving distal perfusion,
and alleviating symptoms.
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persisted, the procedure was repeated with a second ligature (using a
balloon with a diameter 1mm less than that of the first).
Medications. The minimally invasive dissection procedure was
performed regardless of anticoagulation status (Warfarin; Clopidogrel).
Anticoagulants (heparin) were not necessary during the procedure.
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